| 2-AG | 2-Arachidonoylglycerol |
| AEA | Anandamide |
| APF | Antiproliferative factor |
| BPS | Bladder pain syndrome |
| CB1R | Cannabinoid receptor type 1 |
| CB2R | Cannabinoid receptor type 2 |
| CYP | Cyclophosphamide |
| EC | Endocannabinoid |
| ECS | Endogenous cannabinoid system |
| EGF | Epidermal growth factor |
| FAAH | Fatty acid amide hydrolase |
| HB-EGF | Heparin-binding epidermal growth factor |
| IC | Interstitial cystitis |
| IDO | Idiopathic detrusor overactivity |
| IL-6 | Interleukin-6 |
| IL-8 | Interleukin-8 |
| IL-1β | Interleukin-1β |
| TNF-α | Tumor necrosis factor- α |
| i.p. | Intraperitoneal |
| LPS | Lipopolysaccharide |
| MAGL | Monoacylglycerol lipase |
| mRNA | messenger ribonucleic acid |
| NAAA | N-acylethanolamine acid amide hydrolase |
| NGF | Nerve growth factor |
| OEA | Oleoylethanolamide |
| PEA | Palmitoylethanolamide |
| PBS | Painful bladder syndrome |
| qPCR | Quantitative polymerase chain reaction |